Build Payer-Ready Value Dossiers Faster with Smart Automation
The Challenge
Building a Global Value Dossier is a major bottleneck, draining teams with fragmented evidence, manual writing, and payer misalignment. The result is delayed patient access and wasted budgets
The AI-Powered Authoring Co-Pilot
We believe GVDs should be living, adaptive, and payer-ready from day one. We transform the workflow from a series of manual hurdles into a streamlined, automated journey
TPP-to-GVD Alignment: Build with the Payer in Mind
- From the very start,we connect your Target Product Profile (TPP) with payer value frameworks.
- This ensures your clinical endpoints, comparators, and patient-reported outcomes (PROs) are aligned to what payers are looking for, eliminating late-stage rework.
AI-Powered Automation: Cutting Manual Effort by 50-70%
- Our AI Co-Pilot systematically ingests and synthesizes fragmented evidence from diverse sources, including SLRs, clinical trial data, HEOR models, RWE, and PROs.
- This drastically reduces manual effort and provides a structured foundation for your dossier.
Templates & Blueprints: Structured SLR Integration
- We use pre-configured templates that not only organize your GVD content but also streamline Systematic Literature Review (SLR) drafting and synthesis.
- By automatically structuring extracted evidence from publications, clinical trials, and RWE, we ensure your dossier is consistent, payer-ready, and covers all critical sections like disease burden, clinical outcomes, and HEOR, from the very first draft.
Embedded Economics: Payer-Ready by Design
- We auto-link references and embed key economic models—like QALY, ICER, and Budget Impact—directly into the narrative.
- This ensures your value story is supported by evidence and ready for payer negotiations from the first draft.
Human-in-the-Loop: Credibility with Speed
- While our AI delivers compliant, traceable first drafts in weeks, not months, human experts remain central to the process.
- SMEs refine the outputs and ensure regulatory alignment, combining the speed of AI with the credibility of human oversight.
What you Gain
Up to 70% Faster
Secure faster HTA submissions and accelerate patient access to life-saving therapies.
Cost Reduction
Automate repetitive tasks to significantly lower operational costs and maximize ROI.
Enhanced Compliance
Build payer confidence with evidence-backed, compliant dossiers ready for regulatory scrutiny.
Our Differentiating Value Propositions
We go beyond simple content generation to deliver a scalable, end-to-end platform
Modular Architecture
Scalable across molecules, therapeutic areas, and geographies for rapid adaptation.
Compliance Mapping
Templates are configurable for HTA bodies like FDA, EMA, NICE, and CADTH.
Living Dossiers
Dossiers evolve automatically with new clinical trial data and RWE.
Transform Your GVD Workflow with Agilisium's Content Gen
Partner with us to secure faster approvals, optimize pricing negotiations, and deliver therapies to patients when they need them most